Open access
Open access
Powered by Google Translator Translator

Global & Public Health (all articles)

Perspective: The Totality of the Evidence, by Dr. John Ioannidis

27 May, 2020 | 02:29h | UTC

The Totality of the Evidence – Boston Review

See other interesting perspectives from the Boston Review: Models v. Evidence AND Good Science Is Good Science

“Given what we know now, it is reasonable to consider alternatives to population-wide lockdown, even as we focus on protecting those most at risk and support health care systems to care for patients who are sick.”

 


Just the Facts: What Drugs are Safe and Effective for COVID-19?

27 May, 2020 | 02:31h | UTC

Just the Facts: What drugs are safe and effective for COVID-19? – Canadian Journal of Emergency Medicine

Related Guidelines: NIH Coronavirus Disease 2019 (COVID-19) Treatment Guidelines – National Institutes of Health AND Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19 Infection

“Apart from supportive care, there are no current effective therapeutics for COVID-19”

 


SARS-CoV-2 in Pregnancy: A Comprehensive Summary of Current Guidelines

26 May, 2020 | 10:02h | UTC

SARS-CoV-2 in Pregnancy: A Comprehensive Summary of Current Guidelines – Journal of Clinical Medicine

Related: COVID-19 review of national clinical practice guidelines for key questions relating to the care of pregnant women and their babies

 


Perspective: In Pandemic, Many Seeing Upsides to Telemedicine

26 May, 2020 | 09:52h | UTC

Part I: In pandemic, many seeing upsides to telemedicine – CIDRAP

Part II: COVID-19 reveals telehealth barriers, solutions – CIDRAP

 


Report: Smart Testing for COVID-19 Virus and Antibodies

26 May, 2020 | 09:55h | UTC

Smart testing for COVID-19 virus and antibodies – CIDRAP

News Release: In new report, CIDRAP at the University of Minnesota proposes smart and strategic approach to COVID-19 testing

See also: Reports 1 and 2

 


Study: Six Feet May Not Be Far Enough to Stop Coronavirus Transmission

26 May, 2020 | 09:48h | UTC

On coughing and airborne droplet transmission to humans – Physics of Fluids

Commentaries: Six feet not far enough to stop virus transmission in light winds – American Institute of Physics AND Expert reaction to paper studying mechanisms of coughing and airborne transmission of viruses – Science Media Centre AND Why 6 feet may not be enough social distance to avoid COVID-19 – Science News

 


Perspective: “Here’s What Needs to Happen Before We Can All Get Vaccinated for COVID-19”

26 May, 2020 | 09:45h | UTC

Here’s what needs to happen before we can all get vaccinated for COVID-19 – CBC

 


Detailed Report into a Nosocomial Outbreak of COVID-19 in a South African Hospital

26 May, 2020 | 09:38h | UTC

Study tells ‘remarkable story’ about COVID-19’s deadly rampage through a South African hospital – Science

Original Study: Report into a nosocomial outbreak of coronavirus disease 2019 (COVID-19) at Netcare St. Augustine’s Hospital

 

Related Commentary on Twitter

https://twitter.com/EricTopol/status/1264922133722886144

 


WHO Pauses Hydroxychloroquine Arm Of COVID-19 Clinical Trial Due to Safety Concerns

26 May, 2020 | 09:35h | UTC

WHO Pauses Hydroxychloroquine Arm Of COVID-19 Clinical Trial – After Lancet Study Finds Higher Mortality Rate Among Patients Getting The Drug – Health Policy Watch

See also: WHO halts hydroxychloroquine trial for coronavirus amid safety fears – The Guardian AND WHO Halts Hydroxychloroquine Trial Over Safety Concerns – NPR

 


Opinion: The ‘Just Stay Home’ Message Will Backfire

26 May, 2020 | 09:33h | UTC

The ‘Just Stay Home’ Message Will Backfire – The Atlantic

“We need less extreme and more nuanced recommendations for navigating life during the pandemic.”

 

Related Commentary on Twitter

 


Remdesivir for the Treatment of Covid-19 — Preliminary Report

25 May, 2020 | 02:06h | UTC

Remdesivir for the Treatment of Covid-19 — Preliminary Report – New England Journal of Medicine

Commentaries: Preliminary report on NIAID trial of remdesivir – PulmCrit AND Peer-reviewed data shows remdesivir for COVID-19 improves time to recovery – National Institutes of Health AND Covid-19 study details benefits of treatment with remdesivir, and also its limitations – STAT

 

Related Commentary on Twitter (Thread – Click for more)

 


Perspective: The World May Be Overestimating the Power of Vaccines

25 May, 2020 | 01:55h | UTC

The world needs Covid-19 vaccines. It may also be overestimating their power – STAT

 


Hydroxychloroquine and Chloroquine for Covid-19: Large Observational Analysis Finds No Benefit and Possible Harm

25 May, 2020 | 02:03h | UTC

Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis – The Lancet

Commentaries: Chloroquine or hydroxychloroquine for COVID-19: why might they be hazardous? – The Lancet AND What a big new study on malaria drugs as Covid-19 treatments tells us — and what it doesn’t – STAT AND Hydroxychloroquine May Cause More Harm Than Benefit To COVID-19 Patients, Says New Lancet Study – Health Policy Watch

 


Opinion: Why Countries Should Stop Using Anti-malarial Drugs for COVID-19

25 May, 2020 | 02:02h | UTC

Why countries should stop using anti-malarial drugs for COVID-19 – The Conversation

 


Editorial – SARS-CoV2 Vaccines: Slow is Fast

25 May, 2020 | 01:54h | UTC

SARS-CoV2 vaccines: Slow is fast – Science

 


Promising Early Results with New Vaccine from China in Phase I Trial

25 May, 2020 | 01:57h | UTC

Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial – The Lancet

Commentaries: First human trial of COVID-19 vaccine finds it is safe and induces rapid immune response – The Lancet AND Early Study Of Covid-19 Vaccine Developed In China Sees Mixed Results – Forbes AND Coronavirus Vaccine Shows Promising Early Results in China – The New York Times AND A Chinese biotech just published the first human data for its coronavirus vaccine candidate, supporting further trials – Business Insider AND Experts skeptical after researchers report positive vaccine results – CNN AND Two COVID-19 Vaccine Candidates Induce Immune Response In Healthy Volunteers – Health Policy Watch

 


SARS-CoV-2 RNA in Wastewater Anticipated COVID-19 Occurrence in a Low Prevalence Area

25 May, 2020 | 01:47h | UTC

SARS-CoV-2 RNA in wastewater anticipated COVID-19 occurrence in a low prevalence area – Water Research

Related: New Research Examines Wastewater to Detect Community Spread of Covid-19

 


Study: 10 of 60 Patients Treated for COVID-19 Persisted with Positive RT-PCR Results from 4 to 24 Days After Hospital Discharge

25 May, 2020 | 01:50h | UTC

Coronavirus Disease 2019 Test Results After Clinical Recovery and Hospital Discharge Among Patients in China – JAMA Network Open

Commentaries: Expert reaction to study on PCR testing results from 60 people after clinical recovery from COVID-19 – Science Media Centre AND 16% of recovered patients test positive for COVID-19 weeks after discharge: study – UPI

 


Cloth Masks May Prevent Transmission of COVID-19: An Evidence-Based, Risk-Based Approach

25 May, 2020 | 01:42h | UTC

Cloth Masks May Prevent Transmission of COVID-19: An Evidence-Based, Risk-Based Approach – Annals of Internal Medicine

 


WHO: At Least 80 million Children Under One at Risk of Diseases Such as Diphtheria, Measles and Polio as COVID-19 Disrupts Routine Vaccination Efforts

25 May, 2020 | 01:34h | UTC

At least 80 million children under one at risk of diseases such as diphtheria, measles and polio as COVID-19 disrupts routine vaccination efforts, warn Gavi, WHO and UNICEF – World Health Organization

Commentaries: WHO warns millions of children at risk as Covid-19 pandemic disrupts routine vaccinations – STAT AND Polio and Measles Could Surge After Disruption of Vaccine Programs – The New York Times

Related: Indirect Effects of the COVID-19 Pandemic on Maternal and Child Mortality in Low-income and Middle-income Countries

 


Updated CDC School Reopening Guidelines

25 May, 2020 | 01:38h | UTC

CDC School Reopening Guidelines – Centers for Disease Control and Prevention

Commentaries: Everyone Needs To Stop Freaking Out About CDC School Reopening Guidelines – Forbes AND What the CDC guidelines for reopening schools recommend, including mask wearing and closing playgrounds – Business Insider

 


CDC: The Coronavirus ‘Does Not Spread Easily’ From Contaminated Surfaces

25 May, 2020 | 01:39h | UTC

CDC: The coronavirus ‘does not spread easily’ from contaminated surfaces – Business Insider

See also: 6 feet away isn’t enough. Covid-19 risk involves other dimensions, too. – Vox AND Coronavirus Does Not Spread Easily on Surfaces, C.D.C. Says – The New York Times AND CDC Advice On Surface Spread Of COVID-19 ‘Has Not Changed,’ Agency Says – NPR

 


Cohort Study: Prognostic Factors Associated with Adverse Outcomes Among Patients with Covid-19

25 May, 2020 | 01:35h | UTC

Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study – The BMJ

Related Study: Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study – The BMJ

Editorial: Covid-19 care before, during, and beyond the hospital

Commentary: Age, male sex, obesity, and underlying illness risk factors for severe COVID-19 or death – The BMJ

 


Opinion: Ten Reasons why Immunity Passports are a Bad Idea

22 May, 2020 | 04:54h | UTC

Ten reasons why immunity passports are a bad idea – Nature

Related: Ethical and Legal Challenges of COVID-19 Immunity Certificates (articles and commentaries on the subject) AND Privileges and Immunity Certification During the COVID-19 Pandemic – JAMA AND The Ethics of COVID-19 Immunity-Based Licenses (“Immunity Passports”) – JAMA

 


Which Interventions Work Best in a Pandemic?

22 May, 2020 | 04:50h | UTC

Which interventions work best in a pandemic? – Science

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.